CareLit · DOI-Nachweis · Pneumologie
Surfactant alterations and lung fibrosis in a murine model of amiodarone-induced pulmonary fibrosis
DOI 10.1055/s-2007-1032270
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Mahavadi, L Schwertner, T Mokry, I Henneke, M Korfei, W Seeger, A Günther, C Ruppert
ZeitschriftPneumologie
Ausgabe01/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Amiodarone (AD) belongs to the class III antiarrhythmic drugs, and prolongs phase 3 of the cardiac action potential. Because amiodarone has a low incidence of pro-arrhythmic effects, it is now widely used for acute and chronic treatment of (life-threatening) arrhythmias, but the use is limited by the pulmonary toxicity. Amiodarone may cause an acute pulmonary syndrome that appears just like typical pne…
Zitieren
Zitierempfehlung
P Mahavadi, L Schwertner, T Mokry, I Henneke, M Korfei, W Seeger, A Günther, C Ruppert (2008) Surfactant alterations and lung fibrosis in a murine model of amiodarone-induced pulmonary fibrosis. Pneumologie (01). https://doi.org/10.1055/s-2007-1032270
Mit CareLit weiterarbeiten